A new study led by a researcher at Consortium member the Masonic Cancer Center (MCC) provides important new information about the connection between human papillomavirus (HPV) antibodies and five-year survival rates for some types of cancer.
We are pleased to announce a funding opportunity for graduate and professional students on all University of Minnesota campuses. Each year, the Consortium provides funding for intramural projects related to the societal implications of problems in health, environment, and the life sciences. Grants will be awarded in the spring 2017 for work during the summer 2017 and academic year 2017-18. Student organizations may apply for these grants. A total of $35,000 is available with a maximum individual award of $7,000.
In the early 1980s, during the initial throes of the AIDS epidemic, a flight attendant named Gaetan Dugas came to be identified as "Patient Zero" because he was represented in popular culture as the person who brought HIV to North America.
"Would you trust an algorithm to help you with a medical diagnosis?" This question is posed by Christina Farr of Fast Company in her discussion of a collaboration between University of California, San Francisco (UCSF) and General Electric with the goal of finding out what Big Data approaches to diagnosis can – and can't – accomplish.
A recent article in MIT Technology Review examines why men have so few contraceptive choices.
Last night, Andy Slavitt, Acting Administrator of the Centers for Medicare and Medicaid Services (CMS), addressed the annual Biopharma Congress in Washington, DC.
According to an in-depth article in the New York Times, while "the controversy over genetically modified crops has long focused on largely unsubstantiated fears that they are unsafe to eat. .
Prof. Kola Okuyemi, MD, MPH, has been awarded a $1.5M grant from the National Institutes of Health (NIH) to educate researchers about reducing cancer-related health disparities among underserved populations. Prof.
Consortium collaborator Pamala Jacobson, PharmD, FCCP, has been named a Distinguished Professor under the Pharmacy Scholars program. Prof.
An article in The Conversation poses an urgent question: In light of declining federal support, is it time for a new funding model for scientific research in higher education?